ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Association of visceral adiposity index with new-onset type 2 diabetes and impaired fasting glucose in hypertensive Chinese adults

Zhou, Chun; Zhang, Zhuxian; Liu, Mengyi; Zhang, Yuanyuan; He, Panpan; Li, Qinqin; Xie, Di; Liang, Min; Wang, Guobao; Nie, Jing; Liu, Chengzhang; Song, Yun; Liu, Lishun; Wang, Binyan; Wang, Xiaobin; Xu, Xiping; Qin, Xianhui*安徽医科大学; 南方医科大学; 中国农业大学
Eating and Weight Disorders-Studies on Anorexia Bulimia and Obesity2022-3DOI: 10.1007/s40519-021-01187-4
5被引9阅读
引用收藏
分享

摘要

Purpose Visceral adiposity index (VAI) is a reliable indicator for the distribution and function of adipose tissue in the body. The relation of VAI with new-onset type 2 diabetes and new-onset impaired fasting glucose (IFG) remains uncertain. We aimed to investigate the prospective relation of VAI with new-onset type 2 diabetes and new-onset IFG in Chinese hypertensive adults. Methods A total of 14,838 hypertensive adults free of type 2 diabetes at baseline were included from the China Stroke Primary Prevention Trial. The primary outcome was new-onset type 2 diabetes, defined as physician-diagnosed diabetes or use of glucose-lowering drugs during follow-up, or fasting glucose >= 7.0 mmol/L at the exit visit. The secondary outcome was new-onset IFG, defined as fasting glucose < 6.1 mmol/L at baseline, while fasting glucose >= 6.1 mmol/L and < 7.0 mmol/L at the exit visit. Results Over a median of 4.5 years' follow-up, 1612 (10.9%) participants developed type 2 diabetes. When VAI was categorized into quartiles, compared with participants in quartile 1-3 (< 2.80), significantly higher risk of new-onset type 2 diabetes (OR 1.30; 95% CI 1.08-1.56) and new-onset IFG (OR 1.28; 95% CI 1.08-1.52) was found in those in quartile 4 (>= 2.80). Moreover, the positive associations were consistent in participants with or without single abnormal VAI components, including general obesity, abdominal obesity, elevated triglycerides and low high-density lipoprotein cholesterol (HDL-C) levels; or with different numbers of abnormal VAI components (all P interactions > 0.05). Conclusion Our study suggested a positive relation of VAI with the risk of new-onset type 2 diabetes and new-onset IFG in Chinese hypertensive patients, independent of its components.

学科与关键词

关键词
Visceral adiposity indexNew-onset type 2 diabetesNew-onset impair fasting glucoseHypertension
相关
加载中…
  • Novel lipid indicators and the risk of type 2 diabetes mellitus among Chinese hypertensive patients: findings from the Guangzhou Heart Study
    Deng, Hai; Hu, Peng; Li, Huoxing; Zhou, Huanning; Wu, Xiuyi; Yuan, Maohua; Duan, Xueru; Lao, Miaochao; Wu, Chuchu; Zheng, Murui*; Lao, Xiang Qian; Zhao, Wenjing*; Liu, Xudong*Cardiovascular Diabetology, 2022, 21(1): 212.被引 11
  • Relationship of visceral adiposity index with new-onset proteinuria in hypertensive patients
    Liu, Mengyi; Zhou, Chun; Zhang, Zhuxian; He, Panpan; Zhang, Yuanyuan; Xie, Di; Nie, Jing; Liang, Min; Song, Yun; Liu, Chengzhang; Liu, Lishun; Huo, Yong; Wang, Binyan; Wang, Xiaobin; Xu, Xiping*; Qin, Xianhui*CLINICAL NUTRITION, 2021, 40(2): 438-444.被引 10
  • Associations between visceral adiposity index and incident nephropathy outcomes in diabetic patients: Insights from the ACCORD trial
    Zhou, Chun; Zhang, Yanjun; Yang, Sisi; He, Panpan; Wu, Qimeng; Ye, Ziliang; Liu, Mengyi; Zhang, Yuanyuan; Li, Rui; Liu, Chengzhang; Jiang, Jianping; Hou, Fan Fan; Nie, Jing*; Qin, Xianhui*Diabetes/Metabolism Research and Reviews, 2023, 39(3).被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Eating and Weight Disorders-Studies on Anorexia Bulimia and Obesity
发表日期
2022-03
卷期
第 27 卷, 第 2 期
页码
505-514
DOI
10.1007/s40519-021-01187-4
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Key Research and Development Program [2016YFE0205400, 2018ZX09739010, 2018ZX09301034003]; National Key Research and Development Program, China [201707020010]; National Key R&D program of China [2020YFC2005000]; Science, Technology and Innovation Committee of Shenzhen [JSGG20170412155639040, GJHS20170314114526143, JSGG20180703155802047]; Economic, Trade and Information Commission of Shenzhen Municipality [20170505161556110, 20170505160926390]; National Natural Science Foundation of China [81973133, 81730019]; Research Fund Program of Guangdong Province Key Laboratory of Renal Failure Research; Clinical Innovation Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR0201003]

作者

  • Z

    Zhou, Chun (第一作者)

    southern med univ

  • Z

    Zhang, Zhuxian

    southern med univ

查看全部 17 位作者收起作者
  • L

    Liu, Mengyi

    southern med univ

  • Z

    Zhang, Yuanyuan

    southern med univ

  • H

    He, Panpan

    southern med univ

  • L

    Li, Qinqin

    anhui med univ

  • X

    Xie, Di

    southern med univ

  • L

    Liang, Min

    southern med univ

  • W

    Wang, Guobao

    southern med univ

  • N

    Nie, Jing

    southern med univ

  • L

    Liu, Chengzhang

  • S

    Song, Yun

    china agr univ

  • L

    Liu, Lishun

    china agr univ

  • W

    Wang, Binyan

    anhui med univ

  • W

    Wang, Xiaobin

  • X

    Xu, Xiping

    china agr univ · anhui med univ · southern med univ

  • Q

    Qin, Xianhui (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417